BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34602462)

  • 1. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1.
    Yang D; Wang D; Qiu Y; Tian X; Zuo D; Dong Y; Lou W; Wang W
    Clin Hemorheol Microcirc; 2022; 80(4):343-352. PubMed ID: 34602462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
    Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
    Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
    Wang L; Nie F; Dong T; Yin C; Li M; Li Y
    Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors.
    Malagò R; D'Onofrio M; Zamboni GA; Faccioli N; Falconi M; Boninsegna L; Mucelli RP
    AJR Am J Roentgenol; 2009 Feb; 192(2):424-30. PubMed ID: 19155405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study.
    Zhu HB; Zhu HT; Jiang L; Nie P; Hu J; Tang W; Zhang XY; Li XT; Yao Q; Sun YS
    Eur Radiol; 2024 Jan; 34(1):90-102. PubMed ID: 37552258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
    Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
    Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation.
    Kawasaki Y; Hijioka S; Nagashio Y; Maruki Y; Ohba A; Takeshita K; Takasaki T; Agarie D; Hagiwara Y; Hara H; Okamoto K; Yamashige D; Kondo S; Morizane C; Ueno H; Mizui T; Takamoto T; Nara S; Ban D; Esaki M; Tamada K; Hiraoka N; Saito Y; Okusaka T
    J Gastroenterol; 2023 Jul; 58(7):693-703. PubMed ID: 37154933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
    Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration.
    Takano Y; Yamawaki M; Noda J; Azami T; Niiya F; Maruoka N; Yamagami T; Norose T; Ohike N; Nagahama M
    Intern Med; 2023 Dec; 62(24):3585-3590. PubMed ID: 37081682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images.
    Dong Y; Yang DH; Tian XF; Lou WH; Wang HZ; Chen S; Qiu YJ; Wang W; Dietrich CF
    Br J Radiol; 2023 Sep; 96(1149):20220783. PubMed ID: 37393539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.